InvestorsHub Logo

Cardiologymd

09/10/20 8:54 AM

#297982 RE: ziploc_1 #297976

This statement is taken out of contest. Read the whole case. It all revolves about apotex changing the dosing.

Biobillionair

09/10/20 9:49 AM

#297999 RE: ziploc_1 #297976

Zip- Do you have the full case number for AZN vs. Apotex...I need to review this case. Thanks
BB

HinduKush

09/10/20 10:06 AM

#298007 RE: ziploc_1 #297976

Zip
The issue revolves around KNOWING intent OR inducement to infringement..FDA requirements notwithstanding. In the 2012 precedential judgement by CAFC (Rader, Lourie, Moore presiding) the court made clear that as long as the labeling does not incite or de facto induce infringement the genegerics are safe. IF however there was inducement through improper labeling, then the remedy was an injunction..
https://investorshub.advfn.com/uimage/uploads/2020/9/10/kedosastar_zeneca_vs_apotex_rosuvastatin_explained_2012.png

circuitcity

09/10/20 10:21 AM

#298009 RE: ziploc_1 #297976

I would say it worth trying at least, better than en banc at least.

We can debate for ever but it won’t be as clear as day and night as far as it applies to amrn not not. It will be up to the judges. Prior to this fish article case, it was probably considered a long shot too, but brand company made it. So let us try it at least, based on what I read the chance seems no less than the FC appeal.